CSL 0.72% $293.86 csl limited

CSL hopes for flu vaccine by August 2006 23/09/2005 01:05:20 PM...

  1. 337 Posts.
    CSL hopes for flu vaccine by August 2006
    23/09/2005 01:05:20 PM


    Blood products and vaccines developer CSL Ltd hopes to have a vaccine for bird flu ready by August 2006 or earlier in the event of an emergency.

    CSL director of public affairs Rachel David said the company had been working on the development of a vaccine for bird flu for several years.

    "The federal government has recently given us a grant of $4.93 million for us to accelerate our program such that we are currently in a clinical (human phase I) trial of a prototype product that we've already made," she said.

    Advertisement:
    "What we're trying to determine from the trials is the optimum dose to use and whether or not we need to add an adjuvant (a chemical that makes the product more potent) to the products."

    The results from the current trial should be available in December this year.

    "We're aiming to be completely finished by August 2006," Ms David said.

    "However, we have an emergency dossier which we'll put together much, much earlier in case we have a problem that arises sooner, so if worse comes to worst, early next year we will be able to manufacture product for this circulating (bird flu) strain if we need to."

    Ms David said CSL was using identical technology for an existing seasonal flu vaccine that the company makes.

    A bird flu vaccine could be moved quickly to production once trials were completed.

    CSL would manufacture the vaccine at its facility in Parkville, Victoria, where it makes its human flu vaccine.

    "If the strain that causes a flu pandemic is a strain that we know about, and the dose (of the vaccine) is what we expect, we can start getting vaccine out within six weeks and have a complete order filled by three months," Ms David said.

    "So that means we can vaccinate everyone in the country within three months."

    The company would expect to produce 40 million doses of the vaccine in case it needed to give each person two doses.

    CSL shares were $1.04 cents higher at $38.70 at 1256 AEST on Friday.



 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
(20min delay)
Last
$293.86
Change
-2.140(0.72%)
Mkt cap ! $143.3B
Open High Low Value Volume
$294.28 $295.68 $293.59 $17.77M 60.42K

Buyers (Bids)

No. Vol. Price($)
6 85 $293.84
 

Sellers (Offers)

Price($) Vol. No.
$293.90 2 1
View Market Depth
Last trade - 10.24am 18/09/2024 (20 minute delay) ?
CSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.